Adagio Medical (NASDAQ:ADGM – Get Free Report) and Flora Growth (NASDAQ:FLGC – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.
Institutional & Insider Ownership
48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 8.9% of Adagio Medical shares are owned by company insiders. Comparatively, 2.3% of Flora Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Adagio Medical and Flora Growth, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Adagio Medical | 1 | 1 | 2 | 0 | 2.25 |
| Flora Growth | 1 | 0 | 0 | 0 | 1.00 |
Adagio Medical currently has a consensus target price of $3.50, indicating a potential upside of 3,974.51%. Given Adagio Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Flora Growth.
Valuation & Earnings
This table compares Adagio Medical and Flora Growth”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Adagio Medical | $600,000.00 | 3.93 | -$25.08 million | ($1.48) | -0.06 |
| Flora Growth | $57.61 million | 0.05 | -$15.91 million | ($32.49) | -0.09 |
Flora Growth has higher revenue and earnings than Adagio Medical. Flora Growth is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Adagio Medical and Flora Growth’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Adagio Medical | N/A | -661.85% | -73.35% |
| Flora Growth | -32.03% | -64.02% | -34.46% |
Risk & Volatility
Adagio Medical has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.9, meaning that its share price is 90% more volatile than the S&P 500.
Summary
Adagio Medical beats Flora Growth on 9 of the 14 factors compared between the two stocks.
About Adagio Medical
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.
About Flora Growth
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Receive News & Ratings for Adagio Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adagio Medical and related companies with MarketBeat.com's FREE daily email newsletter.
